Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.
about
Natalizumab for relapsing remitting multiple sclerosisReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseBest practice in the use of natalizumab in multiple sclerosis.Natalizumab in the treatment of multiple sclerosisNatalizumab in pediatric multiple sclerosis patients.A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.Treating multiple sclerosis with monoclonal antibodies.Innovative monoclonal antibody therapies in multiple sclerosis.Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?Urticaria mimickers in children.Cutaneous Adverse Effects of Neurologic Medications.Characterization of anti-natalizumab antibodies in multiple sclerosis patients.Switching therapies in multiple sclerosis.Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
P2860
Q24235861-69115F78-761A-4AF8-B7B5-55DA5C1A1FD5Q26822029-42B6AA71-CF3B-4307-9F43-D3145B4A2296Q30597618-54366ED4-EDC7-4436-BB8B-DBC71F5E92F9Q34409340-EB1D7D33-FC06-47F5-AAB4-44065EBBBBC7Q34409523-6C0B3740-8630-4344-9807-B69E77CDC0B5Q34459729-7A8AB491-9B96-4C89-B630-138E8DAB3FA8Q37111904-C55A12DD-DA44-4D0E-BE42-6BF9E01CA0E6Q37823315-6453F723-5413-44B4-A6DF-D76D67E7DD89Q38150405-0F035D6D-607D-425E-B1FF-0DC9A5B20A21Q38152451-AB32F72F-BECF-4CF1-A0D9-23003C2D676EQ38189469-81E86CD3-29BB-489D-B3A6-17E52E6C9EFDQ38749921-8A72D5F0-7569-4DFB-9835-2B23768CBA4AQ44171101-278B4DF3-FAC7-406B-93A8-B81A1759E7D6Q45977173-7B6613B0-7BA0-4ECD-BEFA-9B08C381B6F8Q48349615-5A3EDC0D-C925-491C-8533-99277C419856Q51749279-09827BC8-EF74-461A-85BA-AAB1F36B836E
P2860
Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Delayed allergic reaction to n ...... on of neutralizing antibodies.
@en
type
label
Delayed allergic reaction to n ...... on of neutralizing antibodies.
@en
prefLabel
Delayed allergic reaction to n ...... on of neutralizing antibodies.
@en
P2093
P1433
P1476
Delayed allergic reaction to n ...... on of neutralizing antibodies.
@en
P2093
Hannah Pellkofer
Lisa Ann Hoffmann
Markus Krumbholz
Reinhard Hohlfeld
P304
P356
10.1001/ARCHNEUR.64.9.1331
P577
2007-09-01T00:00:00Z